Effect of sinapic acid against carbon tetrachloride-induced acute hepatic injury in rats

Archives of Pharmacal Research

Volumn 36, Issue 5, 2013, Pages 626-633

  Shin, Dong Su ^a,c   Kim, Kung Wook ^a   Chung, Hae Young ^a   Yoon, Sik ^b   Moon, Jeon Ok ^a  

^a Pusan National University   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

^c Animal Plant and Fisheries Quarantine and Inspection Agency   (South Korea)

Author keywords

Antifibrogenic effect; Antioxidant effect; Hepatic stellate cell; Hepatoprotective effect; IL 1 ; Liver fibrosis; NF B p65; Sinapic acid; TNF

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIINFLAMMATORY AGENT; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MALONALDEHYDE; MESSENGER RNA; SINAPIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEPATIC INJURY; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATTENUATION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; HISTOPATHOLOGY; IN VITRO STUDY; LIVER HISTOLOGY; LIVER INJURY; LIVER PROTECTION; MALE; NONHUMAN; RAT;

EID: 84878240389     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-013-0050-5     Document Type: Article

References (30)

1. Agarwal, R.; and S.D. Chase. 2002. Rapid Fluorimetric-liquid chromatographic determination of malondialdehyde in biological samples. Journal of Chromatography, B: Analytical Technologies in the Biomedical and Life Sciences 775: 121-126.
2. Boigk, G.; L. Stroedter, H. Herbst, J. Waldschmidt, E.O. Riecken, and D. Schuppan. 1997. Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats. Hepatology 26: 643-649.
3. Brand-Williams, W.; and M.E. Cuvelier. 1995. Use of a free radical method to evaluate the antioxidant activity. LWT Food Science and Technology 28: 25-30.
4. 4 to microsomal lipids in rats under varying experimental conditions. Toxicology and Applied Pharmacology 23: 541-552.
5. Ejarque-Ortiz, A.; M.G. Medina, J.M. Tusell, A.P. Perez-Gonzalez, J. Serratosa, and J. Saura. 2007. Upregulation of CCAAT/enhancer binding protein beta in activated astrocytes and microglia. Glia 55: 178-188.
6. Gabele, E.; D.A. Brenner, and R.A. Rippe. 2003. Liver fibrosis: signals leading to the amplification of the fibrotic hepatic stellate cell. Front Bioscience 8: 69-77.
7. Janero, D.R. 1990. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radical Biology & Medicine 9: 515-540.
8. Kawada, N.; S. Seki, M. Inoue, and T. Kuroki. 1998. Effect of antioxidants, reveratol, quercetin, and N-acetylcystein on the function of culture rat hepatic stellate cells and Kupffer cells. Hepatology 2: 1265-1274.
9. Kikuzaki, H.; M. Hisamoto, K. Hirose, K. Akiyama, and H. Taniguchi. 2002. Antioxidant properties of ferulic acid and its related compounds. Journal of Agriculture and Food Chemistry 50: 2161-2168.
10. Kim, D.H.; B.H. Yoon, W.Y. Jung, J.M. Kim, S.J. Park, D.H. Park, Y. Huh, C. Park, J.H. Cheong, K. Lee, C.Y. Shin, and J.H. Ryu. 2010. Sinapic acid attenuates kainic acid-induced hippocampal neuronal damage in mice. Neuropharmacology 1: 1-11.
11. Lee, E.S.; M.O. Shin, S. Yoon, and J.O. Moon. 2010. Resveratrol inhibits dimethylnitrosamine-induced hepatic fibrosis in rats. Archives of Pharmacal Research 33: 925-932.
12. Muriel, P. 2007. Cytokines in liver diseases. In Hepatotoxicity: from genomics to in vitro and in vivo models, ed. S. Sahu, 371-389. West Sussex: John Wiley and Sons LTD.
13. Muriel, P. 2009. NF-kappa B in liver diseases: a target for drug therapy. Journal of Applied Toxicology 29: 91-100.
14. Muriel, P. 1997. Peroxidation of lipids and liver damage. In Antioxidants, Oxidants, and Free radicals, ed. S.I. Baskin, and H. Salem, 237-257. Washington: Taylor and Francis.
15. Natarajan, K.; S. Singh, T.R. Burke, D. Grunberger, and B.B. Aggarwal. 1996. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-κB. Proceedings of the National Academy of Sciences 93: 9090-9095.
16. Okazaki, I.; T. Watanabe, S. Hozawa, M. Arai, and K. Maruyama. 2000. Molecular mechanism of the reversibility of hepatic fibrosis: With special reference to the role of matrix metalloproteinases. Journal of Gastroenterology and Hepatology 15: 26-32.
17. 4 and adequate model of human cirrhosis? Hepatology 3: 112-120.
18. Pierce, R.A.; M.R. Glaug, R.S. Greco, J.W. Mackenzie, C.D. Boyd, and S.B. Deak. 1987. Increased procollagen mRNA levels in carbon tetrachloride-induced liver fibrosis in rats. Journal of Biological Chemistry 262: 1652-1658.
19. Poli, G. 1993. Liver damage due to free radicals. British Medical Bulletin 49: 604-620.
20. Reitman, S.; and S. Frankel. 1957. Estimation of glutamate oxaloacetate transaminase in the serum of liver disease patients. American Journal of Clinical Pathology 28: 56-63.
21. Reyes-Gordillo, K.; J. Segovia, M. Shibayama, P. Vergara, M.G. Moreno, and P. Muriel. 2007. Curcumin protects against acute liver damage in the rat by inhibiting NFkappaB, proinflammatory cytokines production and oxidative stress. Biochimica et Biophysica Acta 1770: 989-996.
22. Ryutaro, T.; S. Tsutomu, and A. Masaki. 2012. The molecular mechanisms of the hepatoprotective effect of gomisin A against oxidative stress and inflammatory response in rats with carbon tetrachloride-induced acute liver injury. Biological & Pharmaceutical Bulletin 35: 171-177.
23. Shahidi, F.; M. Naczk, and Ceials, Legumes, and nuts. 2004. Phenolics in Food and Nutra Ceuticals, 17-166. Boca Raton: CRC press.
24. Shin, M.O.; S. Yoon, and J.O. Moon. 2010. The proanthocyanidins inhibits dimethylnitrosamine-induced hepatic fibrosis in rats. Archives of Pharmacal Research 33: 167-173.
25. Weber, L.W.; M. Boll, and A. Stampfl. 2003. Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Critical Reviews in Toxicology 33: 105-136.
26. Wu, J.; and M.A. Zern. 2000. Hepatic stellate cells: a target for the treatment of liver fibrosis. Journal of Gastroenterology 35: 665-667.
27. Yamamoto, Y.; and R.B. Gaynor. 2001. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. Journal of Clinical Investigation 107: 135-142.
28. Yoon, B.H.; J.W. Jung, J.J. Lee, Y.W. Cho, C.G. Jang, C. Jin, T.H. Oh, and J.H. Ryu. 2007. Anxiolytic-like effects of sinapic acid in mice. Life Sciences 81: 234-240.
29. Yun, K.J.; D.J. Koh, S.H. Kim, S.J. Park, J.H. Ryu, D.G. Kim, J.Y. Lee, and K.T. Lee. 2008. Antiinflammatory effects of sinapic acid through the suppression of inducible nitric oxide synthase, cyclooxygase 2, and proinflammatory cytokine expressions via nuclear factor-kB inactivation. Journal of Agriculture and Food Chemistry 56: 10265-10272.
30. Zou, Y.; A.R. Kim, J.E. Kim, J.S. Choi, and H.Y. Chung. 2002. Peroxynitrite scavenging activity of sinapic acid (3,5-dimethoxy-4- hydroxycinnamic acid) isolated from Brassica juncea. Journal of Agriculture and Food Chemistry 50: 5884-5890.